ZUTRIPRO

Product NDC: 63717-876
11-digit product format: 637170876
Labeler code: 63717
Product ID: 63717-876_4ed25d38-27e1-4ee4-92b5-d3af4dbac6be
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: hydrocodone bitartrate, chlorpheniramine maleate, and pseudoephedrine hydrochloride
Dosage form: SOLUTION
Route: ORAL
Labeler: Hawthorn Pharmaceuticals, Inc.
Application: NDA022439
Marketing category: NDA
Marketing start: 2011-06-08
Marketing end: 0000-00-00
Substance: HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE
Active strength: 5 mg/5mL; mg/5mL; mg/5mL
Pharmacologic classes: Opioid Agonist [EPC],Opioid Agonists [MoA],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
DEA schedule: CII
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	63717-876		D	Discontinued by firm		2026-08-10
excluded package	package	63717-876	63717-876-16	D	Discontinued by firm		2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63717-876-16	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63717-876-16	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63717-876-16	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63717-876-16	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63717-876-16	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63717-876-16	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63717-876-16	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63717-876-16	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63717-876-16	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63717-876-16	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63717-876-16	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63717-876-16	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022439-001	ZUTRIPRO	CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML	SOLUTION / ORAL		RLD	2011-06-08	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML	SOLUTION / ORAL		RLD	2011-06-08	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML	SOLUTION / ORAL		RLD	2011-06-08	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	SOLUTION / ORAL		RLD	2011-06-08	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML	SOLUTION / ORAL		RLD	2011-06-08	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML	SOLUTION / ORAL		RLD	2011-06-08	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML	SOLUTION / ORAL		RLD	2011-06-08	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML	SOLUTION / ORAL		RLD	2011-06-08	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML	SOLUTION / ORAL		RLD	2011-06-08	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML	SOLUTION / ORAL		RLD	2011-06-08	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2011-06-08	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N022439-001	ZUTRIPRO	4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2011-06-08	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-07-19 19:46 UTC	2019-07	N022439-001	AA	1	`ea99ee380514…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
63717-876-16	2020-02-27	C162847	48780-1	9d75b9d0-3625-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use ZUTRIPRO ® safely and effectively. See full prescribing information for ZUTRIPRO. ZUTRIPRO (hydrocodone bitartrate, chlorpheniramine maleate, and pseudoephedrine hydrochloride) oral solution, CII Initial U.S. Approval: 2011
63717-876-16	2020-01-31	C162847	48780-1	9d75b9d0-3625-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use ZUTRIPRO ® safely and effectively. See full prescribing information for ZUTRIPRO. ZUTRIPRO (hydrocodone bitartrate, chlorpheniramine maleate, and pseudoephedrine hydrochloride) oral solution, CII Initial U.S. Approval: 2011

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63717-876-16	ML - Milliliter	63717-876	63049ebf-e747-48ee-93c0-692e648edfea	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CHLORPHENIRAMINE MALEATE	ACTIVE INGREDIENT	V1Q0O9OJ9Z	ZUTRIPRO (HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE) SOLUTION [HAWTHORN PHARMACEUTICALS, INC.]	4
HYDROCODONE BITARTRATE	ACTIVE INGREDIENT	NO70W886KK	ZUTRIPRO (HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE) SOLUTION [HAWTHORN PHARMACEUTICALS, INC.]	4
PSEUDOEPHEDRINE HYDROCHLORIDE	ACTIVE INGREDIENT	6V9V2RYJ8N	ZUTRIPRO (HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE) SOLUTION [HAWTHORN PHARMACEUTICALS, INC.]	4
CHLORPHENIRAMINE	ACTIVE MOIETY	3U6IO1965U	ZUTRIPRO (HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE) SOLUTION [HAWTHORN PHARMACEUTICALS, INC.]	4
HYDROCODONE	ACTIVE MOIETY	6YKS4Y3WQ7	ZUTRIPRO (HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE) SOLUTION [HAWTHORN PHARMACEUTICALS, INC.]	4
PSEUDOEPHEDRINE	ACTIVE MOIETY	7CUC9DDI9F	ZUTRIPRO (HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE) SOLUTION [HAWTHORN PHARMACEUTICALS, INC.]	4
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	ZUTRIPRO (HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE) SOLUTION [HAWTHORN PHARMACEUTICALS, INC.]	4
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	ZUTRIPRO (HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE) SOLUTION [HAWTHORN PHARMACEUTICALS, INC.]	4
GRAPE	INACTIVE INGREDIENT	6X543N684K	ZUTRIPRO (HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE) SOLUTION [HAWTHORN PHARMACEUTICALS, INC.]	4
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	ZUTRIPRO (HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE) SOLUTION [HAWTHORN PHARMACEUTICALS, INC.]	4
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	ZUTRIPRO (HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE) SOLUTION [HAWTHORN PHARMACEUTICALS, INC.]	4
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	ZUTRIPRO (HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE) SOLUTION [HAWTHORN PHARMACEUTICALS, INC.]	4
SACCHARIN SODIUM	INACTIVE INGREDIENT	SB8ZUX40TY	ZUTRIPRO (HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE) SOLUTION [HAWTHORN PHARMACEUTICALS, INC.]	4
SODIUM CITRATE	INACTIVE INGREDIENT	1Q73Q2JULR	ZUTRIPRO (HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE) SOLUTION [HAWTHORN PHARMACEUTICALS, INC.]	4
SUCROSE	INACTIVE INGREDIENT	C151H8M554	ZUTRIPRO (HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE) SOLUTION [HAWTHORN PHARMACEUTICALS, INC.]	4
WATER	INACTIVE INGREDIENT	059QF0KO0R	ZUTRIPRO (HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE) SOLUTION [HAWTHORN PHARMACEUTICALS, INC.]	4

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
NO70W886KK	HYDROCODONE BITARTRATE	34195-34-1	HYDROCODONE BITARTRATE
6V9V2RYJ8N	PSEUDOEPHEDRINE HYDROCHLORIDE	345-78-8	PSEUDOEPHEDRINE HYDROCHLORIDE
V1Q0O9OJ9Z	CHLORPHENIRAMINE MALEATE	113-92-8	CHLORPHENIRAMINE MALEATE